Novartis India Limited (NOVARTIND.BO)

INR 789.4

(0.41%)

Total Liabilities Summary of Novartis India Limited

  • Novartis India Limited's latest annual total liabilities in 2023 was 1.8 Billion INR , down -13.11% from previous year.
  • Novartis India Limited's latest quarterly total liabilities in 2024 Q2 was 1.61 Billion INR , down 0.0% from previous quarter.
  • Novartis India Limited reported annual total liabilities of 2.07 Billion INR in 2022, down -22.04% from previous year.
  • Novartis India Limited reported annual total liabilities of 2.65 Billion INR in 2021, down -8.67% from previous year.
  • Novartis India Limited reported quarterly total liabilities of - INR for 2024 Q1, down -100.0% from previous quarter.
  • Novartis India Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Total Liabilities Chart of Novartis India Limited (2023 - 2007)

Historical Annual Total Liabilities of Novartis India Limited (2023 - 2007)

Year Total Liabilities Total Liabilities Growth
2023 1.8 Billion INR -13.11%
2022 2.07 Billion INR -22.04%
2021 2.65 Billion INR -8.67%
2020 2.91 Billion INR -18.44%
2019 3.56 Billion INR 59.87%
2018 2.23 Billion INR -40.76%
2017 3.76 Billion INR 63.65%
2016 2.3 Billion INR -3.63%
2015 2.38 Billion INR 16.2%
2014 2.05 Billion INR -14.58%
2013 2.4 Billion INR -0.08%
2012 2.4 Billion INR 11.65%
2011 2.15 Billion INR 13.46%
2010 1.9 Billion INR 13.84%
2009 1.67 Billion INR 8.09%
2008 1.54 Billion INR 15.4%
2007 1.33 Billion INR 0.0%

Peer Total Liabilities Comparison of Novartis India Limited

Name Total Liabilities Total Liabilities Difference
Alembic Pharmaceuticals Limited 16.27 Billion INR 88.933%
Aurobindo Pharma Limited 152.2 Billion INR 98.817%
Glenmark Life Sciences Limited 5.18 Billion INR 65.236%
Granules India Limited 22.95 Billion INR 92.154%
Indoco Remedies Limited 10.34 Billion INR 82.585%
Achyut Healthcare Limited 2.01 Million INR -89373.423%
Ajanta Pharma Limited 10.71 Billion INR 83.183%
Alkem Laboratories Limited 48.6 Billion INR 96.294%
Alpa Laboratories Limited 307.12 Million INR -486.444%
Brooks Laboratories Limited 248.6 Million INR -624.494%
AstraZeneca Pharma India Limited 3.66 Billion INR 50.805%
Bajaj HealthCare Limited 4.86 Billion INR 62.999%
Bliss GVS Pharma Limited 2.1 Billion INR 14.593%
Dr. Reddy's Laboratories Limited 106.96 Billion INR 98.316%
Eris Lifesciences Limited 38.26 Billion INR 95.293%
FDC Limited 3.7 Billion INR 51.442%
Glenmark Pharmaceuticals Limited 65.11 Billion INR 97.234%
Gufic Biosciences Limited 5.59 Billion INR 67.836%
Ind-Swift Laboratories Limited 2.28 Billion INR 21.331%
Ipca Laboratories Limited 33.74 Billion INR 94.662%
Jagsonpal Pharmaceuticals Limited 296.76 Million INR -506.921%
Krebs Biochemicals & Industries Limited 2.97 Billion INR 39.437%
Lasa Supergenerics Limited 541.92 Million INR -232.352%
Laurus Labs Limited 42.71 Billion INR 95.783%
Lupin Limited 96.23 Billion INR 98.128%
Mankind Pharma Limited 23.87 Billion INR 92.456%
Medicamen Biotech Limited 940.36 Million INR -91.532%
Medico Remedies Limited 438.24 Million INR -310.981%
Megasoft Limited 1.85 Billion INR 2.808%
NATCO Pharma Limited 10.53 Billion INR 82.899%
Piramal Pharma Limited 74 Billion INR 97.566%
RPG Life Sciences Limited 1.38 Billion INR -30.496%
Sigachi Industries Limited 2.53 Billion INR 28.846%
Sun Pharmaceutical Industries Limited 183.56 Billion INR 99.019%
Suven Pharmaceuticals Limited 2.03 Billion INR 11.46%
Syncom Formulations (India) Limited 1.16 Billion INR -54.573%
Unichem Laboratories Limited 8.06 Billion INR 77.679%
Wanbury Limited 3.15 Billion INR 42.922%
Windlas Biotech Limited 1.76 Billion INR -2.178%
ZIM Laboratories Limited 2.08 Billion INR 13.44%
Zydus Lifesciences Limited 71.79 Billion INR 97.491%
Sun Pharma Advanced Research Company Limited 3.89 Billion INR 53.734%
Divi's Laboratories Limited 18.99 Billion INR 90.516%
Hester Biosciences Limited 3.59 Billion INR 49.896%
Procter & Gamble Health Limited 2.56 Billion INR 29.677%
Amrutanjan Health Care Limited 783.82 Million INR -129.784%
Bal Pharma Limited 2.51 Billion INR 28.279%
Strides Pharma Science Limited 37.68 Billion INR 95.22%
Venus Remedies Limited 1.39 Billion INR -29.315%
Aarti Pharmalabs Limited 8.25 Billion INR 78.17%
Nectar Lifesciences Limited 11.21 Billion INR 83.945%
Shilpa Medicare Limited 12.93 Billion INR 86.073%
Aarti Drugs Limited 11.5 Billion INR 84.344%
IOL Chemicals and Pharmaceuticals Limited 6.32 Billion INR 71.542%
Suven Life Sciences Limited 148.62 Million INR -1111.874%
Ind-Swift Limited 13.45 Billion INR 86.612%
Valiant Laboratories Limited 1.05 Billion INR -70.195%
J. B. Chemicals & Pharmaceuticals Limited 10.7 Billion INR 83.18%
Solara Active Pharma Sciences Limited 14.14 Billion INR 87.266%
Themis Medicare Limited 1.88 Billion INR 4.578%
Hikal Limited 12.99 Billion INR 86.14%
Torrent Pharmaceuticals Limited 82.05 Billion INR 97.805%
Sequent Scientific Limited 8.27 Billion INR 78.232%
Wockhardt Limited 39.87 Billion INR 95.483%
Jubilant Pharmova Limited 61.27 Billion INR 97.061%
Biofil Chemicals and Pharmaceuticals Limited 288.79 Million INR -523.652%
Neuland Laboratories Limited 5.49 Billion INR 67.244%
Morepen Laboratories Limited 4.45 Billion INR 59.615%
Kilitch Drugs (India) Limited 643.88 Million INR -179.725%
Mangalam Drugs & Organics Limited 1.97 Billion INR 8.866%